Clinical trials: Secondary Immunodeficiencies (SID)

Secondary Immunodeficiencies (SID)

Quality Assurance of Secondary Immunodeficiencies (SID) in CLL/MM Patients

• Completed
• Age: 18 years and older
• Observational study
• Results posted

Retrospective, representative registry for quality assurance on diagnosis and therapy of secondary immunodeficiencies (SID) in patients with chronic lymphocytic leukemia (CLL) or multiple myeloma (MM)

Trial name

QS-SID (NCT04172467)

Testing

non-interventional retrospective epidemiological observational study

Where

Germany

Volunteers

1,086 people

Sponsor

AIO-Studien-gGmbH